Ergoteles’s Compugen CGEN Stock Holding History

Ergoteles’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,181	Closed	-$40.9K	–	1319
2022 Q4	$40.9K	Buy	+57,181	New	+$49.9K	﹤0.01%	1314

Other funds holding CGEN

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ACM

Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Ergoteles's CGEN Position: Q1 2023 in Review

Ergoteles sold out of Compugen (CGEN) in Q1 2023, closing a stake of 57,181 shares — an estimated $40.9K sold.

Ergoteles first reported a position in CGEN in Q4 2022 and held it in 1 quarter. The position peaked at $40.9K in Q4 2022. 68 funds tracked by Wall St. Rank hold CGEN as of Q1 2023.

Ergoteles reported no remaining Compugen position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 57,181 Compugen shares in Q1 2023, an estimated $40.9K.
Ergoteles first reported a position in Compugen in Q4 2022 and held it in 1 quarter.
Ergoteles's Compugen position peaked at $40.9K in Q4 2022.
68 funds tracked by Wall St. Rank held Compugen as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.